Skip to main content

Bioceres Crop Solutions Corp.

For the period ended May 12, 2026. Filed May 12, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

May 12, 2026 · Filed May 12, 2026

Use the contents to explore the available documents and sections.

BIOX$0.23+10.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · Management Review

Management Review

Mr. Federico Trucco, Bioceres’ Chief Executive Officer, commented: “This quarter reflects a period of transition and operational refocusing for the Company. While market conditions in several areas of our business remain challenging, and the effects of the transition in Seeds continue to weigh on reported results, we are increasingly focused on strengthening the fundamentals of the organization and prioritizing disciplined execution across the platform.

During the quarter, we continued advancing initiatives aimed at simplifying the organization, improving operational efficiency, strengthening working capital management and improving cash generation and liability management across key operating subsidiaries. In parallel, we are reinforcing governance and internal processes and conducting a strategic review of our continuing operations — including initiatives focused on organizational streamlining and capital allocation optimization — to ensure that capital, management attention, and resources remain aligned with the areas where we believe we can create the greatest long-term value.

We recognize the significance of the events surrounding Pro Farm and the uncertainty generated by the ongoing litigation process. While we continue to pursue the appropriate legal course and evaluate constructive alternatives where possible, our priority remains clear: stabilizing the business, preserving the value of our core operations, and positioning the Company for a more resilient and sustainable future.”

**Key Financial Metrics

Table 1:**3Q26 Key Financial Metrics

(In millions of U.S. dollars)3Q253Q26%CHANGE
Revenue by Segment
Crop Protection30.124.6-18%
Seed and Integrated Products10.93.2-71%
Crop Nutrition10.111.615%
Total Revenue51.139.4-23%
Gross Profit18.112.7-30%
Gross Margin35%32%-310 bpts
3Q253Q26%CHANGE
GAAP Net income or loss2.3(10.0)-528%
Adjusted EBITDA19.1(0.6)-107%

**3Q26 Summary:**Revenue performance in the third quarter reflects mixed demand dynamics across segments, particularly in Crop Protection, together with the ongoing transition in Seeds toward a more asset-light model. While these factors weighed on reported revenues, Crop Nutrition continued to grow, driven by microbeaded fertilizers.

Gross profit and margins declined year over year, reflecting lower revenues, product mix effects, and the impact of a non-recurring obsolescence adjustment in inoculants, associated with inventory normalization efforts during the period.

3BIOCERES CROP SOLUTIONSTHIRD QUARTER 2026

At the same time, the Company continued to execute on cost management and working capital initiatives, resulting in meaningful reductions in operating expenses and improvements in cash conversion dynamics during the quarter.

Profitability metrics were additionally impacted by the absence of prior year non-cash income associated with changes in contractual obligations and intellectual property arrangements as part of the reorganization in Seeds, which affected year-over-year comparability.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.